机构:[1]Cedars Sinai Med Ctr, Biomed Imaging Res Inst, Los Angeles, CA 90048 USA;[2]Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA;[3]Capital Med Univ, Anzhen Hosp, Dept Radiol, Beijing, Peoples R China;医技科室医学影像科首都医科大学附属安贞医院[4]Siemens Healthcare, MR R&D, Los Angeles, CA USA;[5]Siemens Healthcare, MR Collaborat NE Asia, Beijing, Peoples R China
Background: Without the need of contrast media, diffusion-weighted imaging (DWI) has shown great promise for accurate detection of lipid-rich necrotic core (LRNC), a well-known feature of vulnerable plaques. However, limited resolution and poor image quality in vivo with conventional single-shot diffusion-weighted echo planar imaging (SS-DWEPI) has hindered its clinical application. The aim of this work is to develop a diffusion-prepared turbo-spin-echo (DP-TSE) technique for carotid plaque characterization with 3D high resolution and improved image quality. Methods: Unlike SS-DWEPI where the diffusion encoding is integrated in the EPI framework, DP-TSE uses a diffusion encoding module separated from the TSE framework, allowing for segmented acquisition without the sensitivity to phase errors. The interleaved, motion-compensated sequence was designed to enable 3D black-blood DWI of carotid arteries with sub-millimeter resolution. The sequence was tested on 12 healthy subjects and compared with SS-DWEPI for image quality, vessel wall visibility, and vessel wall thickness measurements. A pilot study was performed on 6 patients with carotid plaques using this sequence and compared with conventional contrast-enhanced multi-contrast 2D TSE as the reference. Results: DP-TSE demonstrated advantages over SS-DWEPI for resolution and image quality. In the healthy subjects, vessel wall visibility was significantly higher with diffusion-prepared TSE (p < 0.001). Vessel wall thicknesses measured from diffusion-prepared TSE were on average 35% thinner than those from the EPI images due to less distortion and partial volume effect (p < 0.001). ADC measurements of healthy carotid vessel wall are 1.53 +/- 0.23 x 10(-3) mm(2)/s. In patients the mean ADC measurements in the LRNC area were significantly lower (0.60 +/- 0.16 x 10(-3) mm(2)/s) than those of the fibrous plaque tissue (1.27 +/- 0.29 x 10(-3) mm(2)/s, p < 0.01). Conclusions: Diffusion-prepared CMR allows, for the first time, 3D DWI of the carotid arterial wall in vivo with high spatial resolution and improved image quality over SS-DWEPI. It can potentially detect LRNC without the use of contrast agents, allowing plaque characterization in patients with renal insufficiency.
基金:
NIH/NHLBIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL096119]
语种:
外文
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2013]版:
大类|2 区医学
小类|2 区核医学3 区心脏和心血管系统
最新[2025]版:
大类|2 区医学
小类|2 区心脏和心血管系统2 区核医学
JCR分区:
出版当年[2012]版:
Q1RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGINGQ1CARDIAC & CARDIOVASCULAR SYSTEMS
最新[2024]版:
Q1CARDIAC & CARDIOVASCULAR SYSTEMSQ1RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
第一作者机构:[1]Cedars Sinai Med Ctr, Biomed Imaging Res Inst, Los Angeles, CA 90048 USA;[2]Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA;
通讯作者:
通讯机构:[1]Cedars Sinai Med Ctr, Biomed Imaging Res Inst, Los Angeles, CA 90048 USA;[2]Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA;
推荐引用方式(GB/T 7714):
Xie Yibin,Yu Wei,Fan Zhaoyang,et al.High resolution 3D diffusion cardiovascular magnetic resonance of carotid vessel wall to detect lipid core without contrast media[J].JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE.2014,16(1):-.doi:10.1186/s12968-014-0067-z.
APA:
Xie, Yibin,Yu, Wei,Fan, Zhaoyang,Nguyen, Christopher,Bi, Xiaoming...&Li, Debiao.(2014).High resolution 3D diffusion cardiovascular magnetic resonance of carotid vessel wall to detect lipid core without contrast media.JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE,16,(1)
MLA:
Xie, Yibin,et al."High resolution 3D diffusion cardiovascular magnetic resonance of carotid vessel wall to detect lipid core without contrast media".JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE 16..1(2014):-